Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Stanfield

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1993
Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigenJ M Rini, R L Stanfield, E A Stura, et al.
Infectious Agents and Disease|April 1, 1994
Immune recognition of viral antigensI A Wilson, R L Stanfield, D A Jewell, et al.
Atherosclerosis|April 17, 1998
CI-1011 lowers lipoprotein(a) and plasma cholesterol concentrations in chow-fed cynomolgus monkeysR Ramharack, M A Spahr, C S Sekerke, et al.
Science (New York, N.Y.)|October 11, 1996
An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complexK C Garcia, M Degano, R L Stanfield, et al.
Ciba Foundation Symposium|January 1, 1991
Structural aspects of antibodies and antibody-antigen complexesI A Wilson, R L Stanfield, J M Rini, et al.
The Journal of Biological Chemistry|September 15, 1989
Preliminary crystallographic data and primary sequence for anti-peptide Fab' B13I2 and its complex with the C-helix peptide from myohemerythrinE A Stura, R L Stanfield, T M Fieser, et al.
Bioorganic & Medicinal Chemistry|April 1, 1997
Inhibitors of acyl-CoA:cholesterol acyltransferase: novel trisubstituted ureas as hypocholesterolemic agentsT S Purchase, A D Essenburg, K L Hamelehle, et al.
Journal of Medicinal Chemistry|May 28, 1993
Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 2. Modification of fatty acid anilide ACAT inhibitors: bioisosteric replacement of the amide bondW H Roark, B D Roth, A Holmes, et al.
Journal of Medicinal Chemistry|July 22, 1994
Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 11. Structure-activity relationships of several series of compounds derived from N-(chlorocarbonyl) isocyanateJ A Picard, R F Bousley, H T Lee, et al.
Journal of Medicinal Chemistry|March 15, 1996
Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 17. Structure-activity relationships of several series of compounds derived from N-chlorosulfonyl isocyanateJ A Picard, P M O'Brien, D R Sliskovic, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1993
Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigenJ M Rini, R L Stanfield, E A Stura, et al.
Infectious Agents and Disease|April 1, 1994
Immune recognition of viral antigensI A Wilson, R L Stanfield, D A Jewell, et al.
Atherosclerosis|April 17, 1998
CI-1011 lowers lipoprotein(a) and plasma cholesterol concentrations in chow-fed cynomolgus monkeysR Ramharack, M A Spahr, C S Sekerke, et al.
Science (New York, N.Y.)|October 11, 1996
An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complexK C Garcia, M Degano, R L Stanfield, et al.
Ciba Foundation Symposium|January 1, 1991
Structural aspects of antibodies and antibody-antigen complexesI A Wilson, R L Stanfield, J M Rini, et al.
The Journal of Biological Chemistry|September 15, 1989
Preliminary crystallographic data and primary sequence for anti-peptide Fab' B13I2 and its complex with the C-helix peptide from myohemerythrinE A Stura, R L Stanfield, T M Fieser, et al.
Bioorganic & Medicinal Chemistry|April 1, 1997
Inhibitors of acyl-CoA:cholesterol acyltransferase: novel trisubstituted ureas as hypocholesterolemic agentsT S Purchase, A D Essenburg, K L Hamelehle, et al.
Journal of Medicinal Chemistry|May 28, 1993
Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 2. Modification of fatty acid anilide ACAT inhibitors: bioisosteric replacement of the amide bondW H Roark, B D Roth, A Holmes, et al.
Journal of Medicinal Chemistry|July 22, 1994
Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 11. Structure-activity relationships of several series of compounds derived from N-(chlorocarbonyl) isocyanateJ A Picard, R F Bousley, H T Lee, et al.
Journal of Medicinal Chemistry|March 15, 1996
Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 17. Structure-activity relationships of several series of compounds derived from N-chlorosulfonyl isocyanateJ A Picard, P M O'Brien, D R Sliskovic, et al.
Pageof 5